Sopan Pharmaceuticals Changes IPO Dates; Public Issue to Open from 3rd Baishakh
Summary
Sopan Pharmaceuticals Limited has revised its IPO schedule to open from 3rd Baishakh to 8th Baishakh 2083, offering 34,74,900 units to the public at a face value of Rs. 100 per unit.
Key Points
- Sopan Pharmaceuticals Limited has changed its IPO opening date to 3rd Baishakh, closing on 8th Baishakh, with a possible extension until 17th Baishakh 2083.
- The IPO offers 34,74,900 units to the general public, priced at Rs. 100 per unit, part of a total 42,90,000 shares issued to the public.
- NMB Capital Limited is appointed as the issue manager for the IPO.
- CARE Ratings Nepal Limited upgraded Sopan Pharmaceuticals' issuer rating from CARE-NP B- (Is) to CARE-NP B (Is), signaling a high risk of default.
